Industry veteran Ken Abreu makes the case for approaching market access very early in the process, and elucidates why it's so important. The market access function is an important one, but based on my ...
China on Thursday further shortened its market access negative list, further relaxing market access restrictions, optimizing market access management, and marking new important achievements in the ...
Three Chinese departments, the National Development and Reform Commission (NDRC), Ministry of Commerce, and State Administration for Market Regulation, announced on Tuesday the launch of a campaign to ...
James Chen, CMT is an expert trader, investment adviser, and global market strategist. Thomas J. Brock is a CFA and CPA with more than 20 years of experience in various areas including investing, ...
Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
The global market access solutions market is forecast to grow at a CAGR of 10-12% over the next five years. Key drivers include escalating regulatory complexity, an increased emphasis on value‐based ...
The Global Pharma Contract Commercialization (CCO) Market is expected to witness a CAGR of 5% by 2029. The key factors driving the pharma CCO market growth are growing R&D costs & declining sales of ...
The OECD report highlighted a rapid rise in oncology drug approvals, from four medicines annually between 2004-2011 to 17 and 15 medicines in 2021 and 2022, respectively. 1 Despite this, inequalities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback